AirXpanders Inc. CDI | Income Statement

Fiscal year is January-December. All values AUD Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
-
-
389.90
767.20
5,095.80
Cost of Goods Sold (COGS) incl. D&A
50.80
40.90
1,836.60
6,111.20
11,989.30
Gross Income
50.80
40.90
1,446.60
5,344.00
6,893.50
SG&A Expense
5,909.30
7,028.30
13,319.70
20,379.90
30,161.10
EBIT
5,960.10
7,069.10
14,766.40
25,723.90
37,054.70
Unusual Expense
62.90
56.20
55.50
-
-
Non Operating Income/Expense
15.90
6.10
399.00
67.20
283.10
Interest Expense
191.40
622.50
562.40
335.00
1,038.50
Pretax Income
6,104.40
7,741.80
14,874.20
26,126.20
37,810.00
Income Tax
-
-
-
1.10
1.30
Consolidated Net Income
6,104.40
7,741.80
14,874.20
26,127.20
37,811.30
Net Income
6,104.40
7,741.80
14,874.20
26,127.20
37,811.30
Net Income After Extraordinaries
6,104.40
7,741.80
14,874.20
26,127.20
37,811.30
Net Income Available to Common
6,104.40
7,741.80
14,874.20
26,127.20
37,811.30
EPS (Basic)
0.37
0.47
0.06
0.10
0.11
Basic Shares Outstanding
-
-
256,602.80
272,511.60
340,829.90
EPS (Diluted)
-
-
0.06
0.10
0.11
Diluted Shares Outstanding
-
-
256,602.80
272,511.60
340,829.90
EBITDA
5,909.30
7,028.30
14,652.30
25,404.70
36,184.50

About AirXpanders

View Profile
Address
1047 Elwell Court
Palo Alto California 94303
United States
Employees -
Website http://www.airxpanders.com
Updated 09/14/2018
AirXpanders, Inc. engages in the design, manufacture, sale and distribution of medical devices for breast reconstruction. It offers AeroForm Tissue Expander System for patients undergoing two-stage breast reconstruction following mastectomy. The company was founded by Daniel I.